Xechem International, Inc. (Xechem) is a holding company for Xechem, Inc, a development-stage biopharmaceutical company engaged in the research, development and limited production of niche generic...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTCBB: XKEM) announced today that its subsidiary Xechem Pharmaceuticals Nigeria Ltd. received final approval from the...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTC BB: XKEM) announced today that
Amalfi Research Group, Ltd. has recently completed a research report on
the...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTCBB: XKEM), Dr. Ramesh Pandey,
president and CEO of Xechem International, was interviewed at length by
United Press...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTC BB: XKEM) announced today that
Xechem was well received and applauded for Dr. Pandey’s
work in developing...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTC BB: XKEM) today announced
that it has appointed Mr. Iretiolu Oniyide Managing Director of its
Xechem...
#22: XKEM News Xechem CEO, Dr. Ramesh Pandey to Present at the 10th Annual New York Society of Security Analysts Biotech/Specialty Pharma Industry Conference
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTC BB: XKEM), Dr. Ramesh C. Pandey,
the Chairman and CEO of Xechem International, will present at the 10th
Annual...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--The Chairman and CEO of Xechem International, Inc. (OTC BB: XKEM),
Dr. Ramesh Pandey, was named Marketwatch Readers’
Choice 2006 CEO of the...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTC BB: XKEM) announced today the
results of its Annual Stockholder Meeting, held earlier today at the
company's...
#19: XKEM News Xechem Announces ``Notice of Allowance'' for a Patent Relating to a Method of Treating Sickle Cell Disease With 5-HMF Compound Licensed from VCU
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTC BB: XKEM) announced today the
United States Patent and Trademark Office has issued to Virginia
Commonwealth...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTC BB: XKEM) announced today that
the United States Export Import (Ex-Im) Bank, the official credit export
agency of...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTC BB: XKEM) announced today that it
has received a SBIR grant in the amount of $473,181 from the National ...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Sept. 12, 2006--Xechem International, Inc. (OTC BB: XKEM) announced today that its Chairman and CEO, Dr. Ramesh C. Pandey, has accepted an invitation to make a...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Aug. 16, 2006--The Chairman of Xechem International, Inc. (OTC BB: XKEM), Dr. Ramesh C. Pandey, responded today to a number of questions posed by investors and...
#14: XKEM News Demand for New Sickle Cell Drug NICOSAN(TM) Far Exceeds Supply; Xechem Nigeria Accelerates Construction of Commercial Scale Production Facility
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--July 26, 2006--Xechem International, Inc. (OTC BB: XKEM) announced today that response to the first limited sales and distribution of NICOSAN(TM), its new...
